Dept. of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, Australia.
Dept. of Immunology and Pathology, Monash University, Melbourne, Australia.
Respir Res. 2020 Aug 26;21(1):221. doi: 10.1186/s12931-020-01467-0.
CXCR4, a transmembrane-receptor located on epithelial cells that is activated by CXCL12, may have a role in IPF via migration of CXCR4 fibrocytes to the lung. However, its expression has not been fully characterised in idiopathic pulmonary fibrosis (IPF) or other fibrotic interstitial lung diseases (ILDs). CXCL12 is constitutively expressed in the bone marrow, and levels of CXCR4 regulate control of this signalling pathway. The aim of this study was to profile the expression of CXCR4 in lung tissue and peripheral circulation of patients with IPF and other fibrotic ILDs.
Expression of CXCR4 on peripheral blood mononuclear cells (PBMCs) was examined by flow cytometry in 20 patients with IPF and 10 age-matched non-disease control (NDC) donors. Levels of CXCL12 in human plasma were measured by ELISA. Expression of CXCR4, CXCL12, CD45, and e-cadherin was assessed in IPF (n = 10), other fibrotic ILD (n = 8) and NDC (n = 10) lung tissue by multiplex immunohistochemistry (OPAL) and slides were scanned using a Vectra 3 scanner. Cells were quantified with computer automated histological analysis software (HALO).
In blood, the number of CXCR4 cells was lower but the level of CXCL12 was higher in patients with IPF compared to NDC donors. Elevated CXCR4 expression was detected in lung tissue from patients with IPF and other fibrotic ILDs compared to NDC. There were higher levels of CXCR4/e-cadherin/CXCL12 (epithelial) cells in IPF lung tissue compared to NDC, but there was no difference in the numbers of CXCR4/CD45/CXCL12 (myeloid) cells between the two groups.
This report demonstrates that CXCR4 is overexpressed not only in IPF but also in other ILDs and expression is particularly prominent within both honeycomb cysts and distal airway epithelium. This observation supports the hypothesis that CXCR4 may drive tissue fibrosis through binding its specific ligand CXCL12. Although CXCR4 expressing cells could be either of epithelial or myeloid origin it appears that the former is more prominent in IPF lung tissue. Further characterization of the cells of the honeycomb cyst may lead to a better understanding of the fibrogenic processes in IPF and other end-stage fibrotic ILDs.
CXCR4 是一种位于上皮细胞上的跨膜受体,可被 CXCL12 激活,可能通过 CXCR4 纤维母细胞向肺部迁移在特发性肺纤维化(IPF)中发挥作用。然而,其在特发性肺纤维化(IPF)或其他纤维性间质性肺疾病(ILDs)中的表达尚未完全描述。CXCL12 在骨髓中持续表达,并且 CXCR4 水平调节对该信号通路的控制。本研究的目的是描绘 IPF 和其他纤维性 ILD 患者肺组织和外周循环中 CXCR4 的表达。
通过流式细胞术检查 20 例 IPF 患者和 10 例年龄匹配的非疾病对照(NDC)供体外周血单个核细胞(PBMC)中 CXCR4 的表达。通过 ELISA 测量人血浆中 CXCL12 的水平。通过多重免疫组化(OPAL)评估 IPF(n=10)、其他纤维性 ILD(n=8)和 NDC(n=10)肺组织中 CXCR4、CXCL12、CD45 和 E-钙粘蛋白的表达,并使用 Vectra 3 扫描仪扫描载玻片。使用计算机自动组织学分析软件(HALO)对细胞进行定量。
与 NDC 供体相比,IPF 患者血液中的 CXCR4 细胞数量较低,但 CXCL12 水平较高。与 NDC 相比,IPF 和其他纤维性 ILD 患者的肺组织中检测到 CXCR4 表达升高。与 NDC 相比,IPF 肺组织中 CXCR4/E-钙粘蛋白/CXCL12(上皮)细胞水平较高,但两组间 CXCR4/CD45/CXCL12(髓样)细胞数量无差异。
本报告表明,CXCR4 不仅在 IPF 中过度表达,而且在其他 ILD 中也过度表达,其表达在蜂窝状囊肿和远端气道上皮中尤为明显。这一观察结果支持了 CXCR4 可能通过与其特异性配体 CXCL12 结合来驱动组织纤维化的假说。尽管 CXCR4 表达细胞可能来自上皮细胞或髓样细胞,但前者在 IPF 肺组织中更为突出。对蜂窝状囊肿的细胞进一步特征分析可能有助于更好地理解 IPF 和其他终末期纤维性 ILD 的纤维化过程。